CHR

Cheer Holding, Inc.

There isn't enough reported data to score CHR yet.

NBIS

Nebius Group N.V.

There isn't enough reported data to score NBIS yet.

CHR Fundamentals

MetricStatus
Under pressure
Healthy
Stable
Healthy

CHR's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is under pressure.

NBIS Fundamentals

MetricStatus
Unavailable
Healthy
Unavailable
Healthy

NBIS's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.

CHR PE Valuation

CHR has no meaningful PE right now: it lost money over the past year.

NBIS PE Valuation

CHEAPFAIREXPENSIVE226x452x678x904x
CHEAPFAIREXPENSIVE226x452x678x904x
LevelPEPriceVs current
Cheap68x$22.45-83%
Fair114x$37.67-71%
Current390x$129โ€”
Expensive666x$220+71%

Historical ranges are pointers, not guarantees.

NBIS's PE is 390x, but its earnings don't support one, so it isn't a reliable read right now.

CHR Forward outlook

There aren't enough analyst estimates for CHR to show an outlook.

NBIS Forward outlook

MetricOutlook
--
Losses steady
Strong growth
Strongly improving
Limited
Low

Analysts expect NBIS's revenue to grow and its profitability to improve, with its earnings holding steady. However, they disagree widely on these estimates.

CHR Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $1.32 on Nov 12.

There is not enough scenario data to compare CHR and NBIS's risk to reward.

NBIS Risk to reward

ScenarioChangePrice
UpsideUnknownโ€”
DownsideUnknownโ€”

Calculated from the latest close: $128.64 on Nov 12.

There is not enough scenario data to compare CHR and NBIS's risk to reward.

CHR Earnings Per Share

Q1 2025: $303.53Q2 2025: $292.24
Q1 2025: $303.53Q2 2025: $292.24

CHR and NBIS do not have enough comparable growth data to identify a winner.

NBIS Earnings Per Share

Q4 2014: $0.63Q4 2015: $0.36Q4 2016: $0.25Q4 2017: $0.32Q4 2018: $1.71Q4 2019: $0.46Q4 2020: $0.87Q4 2021: $-0.49Q4 2022: $1.00Q4 2023: $0.64Q4 2024: $-2.28Q4 2025: $0.33
Q4 2014: $0.63Q4 2015: $0.36Q4 2016: $0.25Q4 2017: $0.32Q4 2018: $1.71Q4 2019: $0.46Q4 2020: $0.87Q4 2021: $-0.49Q4 2022: $1.00Q4 2023: $0.64Q4 2024: $-2.28Q4 2025: $0.33
QuarterTTM EPSYoY
Q4 2025$0.33+$2.61
Q4 2024-$2.28-456%
Q4 2023$0.64-36%
Q4 2022$1.00+$1.49
Q4 2021-$0.49-156%
Q4 2020$0.87+89%
Q4 2019$0.46-73%
Q4 2018$1.71+434%

NBIS has returned to profit: it earned $0.33 per share over the past year, after losing money the year before.

CHR Quarterly Revenue

Q3 2023: --Q4 2023: $85MQ1 2024: --Q2 2024: $71MQ3 2024: $38MQ4 2024: $38MQ1 2025: $35MQ2 2025: $35MQ3 2025: $39MQ4 2025: $39MQ1 2026: $30MQ2 2026: $30M
Q3 2023: --Q4 2023: $85MQ1 2024: --Q2 2024: $71MQ3 2024: $38MQ4 2024: $38MQ1 2025: $35MQ2 2025: $35MQ3 2025: $39MQ4 2025: $39MQ1 2026: $30MQ2 2026: $30M
QuarterRevenueYoY
Q2 2026$30.3M-15%
Q1 2026$30.3M-15%
Q4 2025$38.9M+2.2%
Q3 2025$38.9M+2.2%
Q2 2025$35.5M-50%
Q4 2024$38.1M-55%
Q2 2024$71.1M+5.4%
Q4 2023$84.9M-2.6%

CHR has the edge over NBIS in the latest year-over-year revenue comparison.

NBIS Quarterly Revenue

Q4 2014: $613MQ4 2015: $722MQ4 2016: $917MQ4 2017: $1.1BQ4 2018: $1.5BQ4 2019: $2.1BQ4 2020: $2.6BQ4 2021: $4.3BQ4 2022: $6.3BQ4 2023: $9.7BQ4 2024: --Q4 2025: $530M
Q4 2014: $613MQ4 2015: $722MQ4 2016: $917MQ4 2017: $1.1BQ4 2018: $1.5BQ4 2019: $2.1BQ4 2020: $2.6BQ4 2021: $4.3BQ4 2022: $6.3BQ4 2023: $9.7BQ4 2024: --Q4 2025: $530M
QuarterRevenueYoY
Q4 2023$9.7B+53%
Q4 2022$6.3B+46%
Q4 2021$4.3B+63%
Q4 2020$2.6B+24%
Q4 2019$2.1B+37%
Q4 2018$1.5B+36%
Q4 2017$1.1B+24%
Q4 2016$917M+27%

NBIS's revenue is growing: $530M last quarter, down 80% from the same quarter a year ago.

CHR Free Cash Flow

Q3 2023: $7MQ4 2023: $15MQ1 2024: โˆ’$3MQ2 2024: โˆ’$7MQ3 2024: $15MQ4 2024: $15MQ1 2025: $2MQ2 2025: $2MQ3 2025: $7MQ4 2025: $7MQ1 2026: $18MQ2 2026: โˆ’$15M
Q3 2023: $7MQ4 2023: $15MQ1 2024: โˆ’$3MQ2 2024: โˆ’$7MQ3 2024: $15MQ4 2024: $15MQ1 2025: $2MQ2 2025: $2MQ3 2025: $7MQ4 2025: $7MQ1 2026: $18MQ2 2026: โˆ’$15M
QuarterFree cash flowYoY
Q2 2026-$15.1M-871%
Q1 2026$17.9M+815%
Q4 2025$7M-53%
Q3 2025$7M-53%
Q2 2025$2M+$8.7M
Q1 2025$2M+$5.3M
Q4 2024$14.8M-1.3%
Q3 2024$14.8M+97%

CHR usually generates cash, though not every quarter: the latest was โˆ’$15M, but it generated $17M over the past year.

NBIS Free Cash Flow

Q4 2014: $71MQ4 2015: $79MQ4 2016: $191MQ4 2017: $137MQ4 2018: โˆ’$1MQ4 2019: $288MQ4 2020: $97MQ4 2021: โˆ’$427MQ4 2022: โˆ’$107MQ4 2023: โˆ’$246MQ4 2024: โˆ’$562MQ4 2025: โˆ’$3.7B
Q4 2014: $71MQ4 2015: $79MQ4 2016: $191MQ4 2017: $137MQ4 2018: โˆ’$1MQ4 2019: $288MQ4 2020: $97MQ4 2021: โˆ’$427MQ4 2022: โˆ’$107MQ4 2023: โˆ’$246MQ4 2024: โˆ’$562MQ4 2025: โˆ’$3.7B
QuarterFree cash flowYoY
Q4 2025-$3.7B-$3.1B
Q4 2024-$562.1M-$316.2M
Q4 2023-$245.9M-$138.9M
Q4 2022-$107M+$319.7M
Q4 2021-$426.7M-539%
Q4 2020$97.3M-66%
Q4 2019$287.9M+$289.2M
Q4 2018-$1.3M-101%

NBIS has burned cash in six of the last eight quarters: โˆ’$4.6B over the past year, against โˆ’$43M the year before.

CHR Total Shares

Q4 2023: 201,400Q2 2024: 201,177Q3 2024: 70,637Q4 2024: 70,637Q1 2025: 77,222Q2 2025: 77,222
Q4 2023: 201,400Q2 2024: 201,177Q3 2024: 70,637Q4 2024: 70,637Q1 2025: 77,222Q2 2025: 77,222
PeriodChange %Net change
Quarterly0%--
1 year-62%-124K shares
3 years+1564%+72.6K shares

CHR has the edge over NBIS on shareholder dilution, with a more favorable share count trend.

NBIS Total Shares

Q4 2014: 326MQ4 2015: 324MQ4 2016: 326MQ4 2017: 331MQ4 2018: 335MQ4 2019: 335MQ4 2020: 353MQ4 2021: 362MQ4 2022: 377MQ4 2023: 373MQ4 2024: 281MQ4 2025: 248M
Q4 2014: 326MQ4 2015: 324MQ4 2016: 326MQ4 2017: 331MQ4 2018: 335MQ4 2019: 335MQ4 2020: 353MQ4 2021: 362MQ4 2022: 377MQ4 2023: 373MQ4 2024: 281MQ4 2025: 248M
PeriodChange %Net change
Quarterly-12%-33.3M shares
1 year-32%-115M shares
3 years-26%-86.9M shares

NBIS has 248M diluted shares, down 32% from a year ago.

CHR Net Leverage

Q1 2025: -5.7xQ2 2025: -7.5xQ3 2025: -7.6xQ4 2025: -6.7xQ1 2026: -5.0xQ2 2026: -4.8x
Q1 2025: -5.7xQ2 2025: -7.5xQ3 2025: -7.6xQ4 2025: -6.7xQ1 2026: -5.0xQ2 2026: -4.8x
QuarterNet LeverageStatus
Q2 2026-4.8xNet Cash
Q1 2026-5.0xNet Cash
Q4 2025-6.7xNet Cash
Q3 2025-7.6xNet Cash
Q2 2025-7.5xNet Cash
Q1 2025-5.7xNet Cash

CHR has more cash than debt.

NBIS Net Leverage

Q4 2022: -0.7xQ4 2023: 0.7x
Q4 2022: -0.7xQ4 2023: 0.7x
QuarterNet LeverageStatus
Q4 20230.7xVery low
Q4 2022-0.7xNet Cash

NBIS's net debt is less than a year of its operating earnings (EBITDA).

CHR Weekly Momentum

MetricValueStatus
RSI25.6Oversold
Stochastic15.4Oversold

CHR's weekly RSI is 26 (oversold) and its Stochastic is 15 (oversold).

NBIS Weekly Momentum

MetricValueStatus
RSI38.0Neutral
Stochastic8.3Oversold

NBIS's weekly RSI is 38 (neutral) and its Stochastic is 8 (oversold).

CHR PE vs Communication Services Sector

CHR has no meaningful PE right now: it lost money over the past year.

NBIS PE vs Communication Services Sector

MetricNBISSector medianRelative
PE390x16x2,264% above
PE %622438 pts above

NBIS is trading at 390x earnings, a 2264% premium to the Communication Services sector's median of 16x, though its earnings don't support one.

CHR Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.437.7% below
20 week MA$1.6721% below
50 week MA$2.5949% below
100 week MA$103.999% below
200 week MA$363.1100% below

NBIS has stronger trend alignment. CHR is above 0 of 5 weekly averages versus NBIS above 1 of 4.

NBIS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$179.728% below
20 week MA$199.936% below
50 week MA$163.521% below
100 week MA$110.017% above

NBIS has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 17% above its 100-week average.

CHR Yearly ROI

YearStart priceEnd priceROI
2020$15,450.0$3,945.0-74%
2021$3,945.0$1,935.0-51%
2022$1,935.0$2,220.0+15%
2023$2,220.0$471.0-79%
2024$471.0$387.0-18%
2025$387.0$4.38-99%
2026 YTD$4.38$1.32-70%

CHR has finished three years in a row lower, and it's down 70% so far in 2026.

NBIS Yearly ROI

YearStart priceEnd priceROI
2024$19.6$27.3+40%
2025$27.3$87.6+221%
2026 YTD$87.6$128.6+47%

NBIS has the edge over CHR on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key